Christophe Dorandeu

A propos

Contact
Parcours

Institut Charles Gerhardt Montpellier

Christophe DORANDEU
ITA - AI, Equipe MACS
15 avenue Charles Flahault BP 14491 34093 Montpellier Cedex 5

04-11-75-94-50
christophe.dorandeu@umontpellier.fr

2009-présent : Equipe MACS – ICGM, UFR Pharmacie, Montpellier
2000-2009 : Laboratoire de Biophysique-Bioanalyses, UFR Pharmacie, Montpellier

Thème de Recherche

Nanotechnologies en santé
Chimie sol-gel
Caractérisation des systèmes dispersés
Formulations pharmaceutiques
Liposomes, bicouches lipidiques

Biocompatibility assessment of functionalized magnetic mesoporous silica nanoparticles in human HepaRG cells

PUBLICATION LINK

The species origin of the serum in the culture medium influences the in vitro toxicity of silica nanoparticles to HepG2 cells

PUBLICATION LINK

Biological Fate of Fe3O4 Core-Shell Mesoporous Silica Nanoparticles Depending on Particle Surface Chemistry

PUBLICATION LINK

Experimental separation steps influence the protein content of corona around mesoporous silica nanoparticles

PUBLICATION LINK

Synthesis, decoration, and cellular effects of magnetic mesoporous silica nanoparticles

PUBLICATION LINK

Formulation, physicochemical characterization and stability study of lithium-loaded microemulsion system

PUBLICATION LINK

Retour en haut

2021

Giang Ngo, Gautier Félix, Christophe Dorandeu, Jean-Marie Devoisselle, Luca Costa, Pierre-Emmanuel Milhiet, Yannick Guari, Joulia Larionova and Joël Chopineau
A Novel Approach to the Facile Growth and Organization of Photothermal Prussian Blue Nanocrystals on Different Surfaces,
Nanomaterials 2021, 11, 1749

2019

L. Simon, M. Vincent, S. Le Sauh, V. Lapinte, N. Marcotte, M. Morille, C. Dorandeu, J.-M. Devoisselle and S. Bégu
Polyoxazolines based mixed micelles as PEG free formulations for an effective quercetin antioxidant topical delivery,
Int. J. Pharm. 2019, 570, 118516

2018

Estelle Rascol, Cédric Pisani, Christophe Dorandeu, Jeff Nyalosaso, Clarence Charnay, Morgane Daurat, Afitz Silva, Jean-Marie Devoisselle, Jean Gaillard, Jean Armengaud, Odette Prat, Marie Maynadier, Magali Gary-Bobo, Marcel Garcia, Joel Chopineau and Yannick Guari
Biosafety of Mesoporous Silica Nanoparticles,
Biomimetics 2018, 3, 22

2017

Adrien Chouchou, Anne Aubert‑Pouëssel, Christophe Dorandeu, Zahraa Zghaib, Pierre Cuq, Jean‑Marie Devoisselle, Pierre‑Antoine Bonnet, Sylvie Bégu and Carine Deleuze‑Masquefa
Lipid nanocapsules formulation and cellular activities evaluation of a promising anticancer agent: EAPB0503,
International Journal of Pharmaceutical Investigation 2017, 7, 155-163
Cedric Pisani, Estelle Rascol, Christophe Dorandeu, Clarence Charnay, Yannick Guari, Joel Chopineau, Jean-Marie Devoisselle and Odette Prat
Biocompatibility assessment of functionalized magnetic mesoporous silica nanoparticles in human HepaRG cells,
Nanotoxicology 2017, 11, 871-890
Cedric Pisan, Estelle Rascol, Christophe Dorandeu, Jean-Charles Gaillard, Clarence Charnay, Yannick Guari, Joel Chopineau, Jean Armengaud, Jean-Marie Devoisselle and Odette Prat
The species origin of the serum in the culture medium influences the in vitro toxicity of silica nanoparticles to HepG2 cells,
PLoS One 2017, 12, 0182906
Estelle Rascol, Morgane Daurat, Afitz Da Silva, Marie Maynadier, Christophe Dorandeu, Clarence Charnay, Marcel Garcia, Joséphine Lai-Kee-Him, Patrick Bron, Mélanie Auffan, Wei Liu, Bernard Angeletti, Jean-Marie Devoisselle, Yannick Guari, Magali Gary-Bobo and Joël Chopineau
Biological Fate of Fe₃O₄ Core-Shell Mesoporous Silica Nanoparticles Depending on Particle Surface Chemistry,
Nanomaterials 2017, 7, 162
C. Pisani, J.-C. Gaillard, C. Dorandeu, C. Charnay, Y. Guari, J. Chopineau, J.-M. Devoisselle, J. Armengaud and O. Prat
Experimental separation steps influence the protein content of corona around mesoporous silica nanoparticles,
Nanoscale 2017, 9, 5769-5772

2016

Nyalosaso L. Jeff, Estelle Rascol, C. Pisani, Christophe Dorandeu, Xavier Dumail, Marie Maynadier, Magali Gary-Bobo, Patrick Bron, Marcel Garcia, Jean-Marie Devoisselle, Odette Prat, Yannick Guari, Clarence Charnay and Joel Chopineau
Synthesis, decoration, and cellular effects of magnetic mesoporous silica nanoparticles,
RSC Adv. 2016, 6, 57275-57283
T. Hatahet, M. Morille, A. Hommoss, C. Dorandeu, R. H. Müller and S. Bégu
Dermal quercetin smartCrystals®: Formulation development, antioxidant activity and cellular safety,
Eur. J. Pharm. Biopharm. 2016, 102, 51-63
Abdelkader Mouri, Philippe Legrand, Abdeslam El Ghzaoui, Christophe Dorandeu, Jean Claude Maurel and Jean-Marie Devoisselle
Formulation, physicochemical characterization and stability study of lithium-loaded microemulsion system,
Int. J. Pharm. 2016, 502, 117-124

2015

Abdelkader Mouri, Olivier Diat, Abdeslam El Ghzaoui, Isabelle Ly, Christophe Dorandeu, Jean Claude Maurel, Jean-Marie Devoisselle and Philippe Legrand
Development of pharmaceutical clear gel based on Peceol®, lecithin, ethanol and water: Physicochemical characterization and stability study,
J. Colloid Interface Sci. 2015, 457, 152-161

2014

Abdelkader Mouri, Olivier Diat, Dan Alain Lerner, Abdeslam El Ghzaoui, Alessia Ajovalasit, Christophe Dorandeu, Jean-Claude Maurel, Jean-Marie Devoisselle and Philippe Legrand
Water solubilization capacity of pharmaceutical microemulsions based on Peceol®, lecithin and ethanol,
Int. J. Pharm. 2014, 475, 324-334
Abdelkader Mouri, Olivier Diat, Abdeslam El Ghzaoui, Caroline Bauer, Jean Claude Maurel, Jean-Marie Devoisselle, Christophe Dorandeu and Philippe Legrand
Phase behavior of reverse microemulsions based on Peceol,
J. Colloid Interface Sci. 2014, 416, 139-146

Institut Charles Gerhardt Montpellier - Direction

UMR 5253 - CNRS/UM/ENSCM

Université de Montpellier
Place Eugène Bataillon
CC 1700 - Bâtiment 17 -1er étage
Tel: +33 (0)4 67 14 93 50
Email: direction@icgm.fr

Liens

Etablissements partenaires

Top